Haemonetics

Haemonetics is a mission-driven, publicly-traded leader in hematology-focused medical devices and software. The company has achieved a dominant position in the plasma and blood collection markets through its innovative apheresis systems, data analytics platforms, and surgical solutions, creating a recurring revenue model with high customer retention. Its strategy centers on leveraging its integrated technology ecosystem to drive operational efficiency for customers, expand into adjacent hospital hemostasis markets, and capitalize on the growing global demand for plasma-derived therapies. Haemonetics' consistent execution and recent FDA clearances for next-generation systems underscore its sustainable growth trajectory.

An integrated ecosystem of hardware (apheresis systems), software (data & donor management), and single-use disposables designed to optimize the entire blood and plasma supply chain, from collection to transfusion.

Haemonetics is a market leader in plasma collection (vs. Fresenius Kabi) and a strong competitor in blood center apheresis (vs. Terumo BCT) and hospital hemostasis (vs. Werfen's ROTEM). Its integrated ecosystem of hardware, software, and disposables creates high switching costs and a durable competitive moat.